<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo>, aggravation of <z:hpo ids='HP_0001744'>splenomegaly</z:hpo> was reported as an adverse effect of erythropoietin (EPO) </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, we experienced the adverse effect of EPO in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>A 65-year-old male was admitted to our hospital for scrutiny of <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> in July 8, 1991 </plain></SENT>
<SENT sid="3" pm="."><plain>He was diagnosed as having <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (<z:hpo ids='HP_0005505'>refractory anemia</z:hpo>: RA) </plain></SENT>
<SENT sid="4" pm="."><plain>After discharge, daily subcutaneous administration of EPO (3,000U) was started on August 1 because his Hb concentration had decreased to 9.2 g/dl </plain></SENT>
<SENT sid="5" pm="."><plain>After the daily dose of EPO was increased up to 6,000U in August 15, left hypochondralgia gradually developed </plain></SENT>
<SENT sid="6" pm="."><plain>EPO administration was haltedon August 22 </plain></SENT>
<SENT sid="7" pm="."><plain>His <z:hpo ids='HP_0001744'>splenomegaly</z:hpo> was aggravated from 2 finger breadths below the left costal margin before EPO administration to 4.5 finger breadths </plain></SENT>
<SENT sid="8" pm="."><plain>Bone marrow examination revealed a change to extremely hypercellular marrow from slightly <z:e sem="disease" ids="C0151773" disease_type="Disease or Syndrome" abbrv="">hypocellular marrow</z:e> before EPO administration </plain></SENT>
<SENT sid="9" pm="."><plain>The peripheral blood cell count was not altered </plain></SENT>
<SENT sid="10" pm="."><plain>We concluded that he was a rare case of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in which aggravation of <z:hpo ids='HP_0001744'>splenomegaly</z:hpo> was observed, probably as a result of <z:hpo ids='HP_0001978'>extramedullary hematopoiesis</z:hpo> induced by administration of EPO </plain></SENT>
</text></document>